Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "BioPharma Announces Publication Pacritinib Phase PERSIST Clinical Trial" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about BioPharma Announces Publication Pacritinib Phase PERSIST Clinical Trial for you to read. Along with our medical data and news we also list BioPharma Announces Publication Pacritinib Phase PERSIST Clinical Trial Clinical Trials, which are updated daily. BioPortfolio also has a large database of BioPharma Announces Publication Pacritinib Phase PERSIST Clinical Trial Companies for you to search.
Advanced Aesthetic Technologies, Inc. (ATT), a leader in aesthetic gel implant technology, today announced the appointment of Doug Abel as Chief Executive Officer and President, effective immediately. Mr. Abel will lead the Company’s global initiative and advance the development of its gel technology for the aesthetic and healthcare markets. Ric...
A UK based biotech firm has been awarded a grant to develop a treatment for osteoarthritis, after promising results from a Phase I trial... The post Biotech firm awarded for approach to drug development appeared first on
The U.S. FDA has announced new, efficient guidelines for the use of a novel pathway that provides incentives for developing generic versions of drugs that currently face little or no competition.
The symposium will be held in conjunction with the Academy of Managed Care Pharmacy’s annual meeting Pharmacy Times Continuing Education™ (PTCE), a leader in continuing education for retail, health-system, managed care and specialty pharmacists, will conduct a live satellite symposium titled Managing Treatment Gaps with PCSK9 Inhibitors in conjunct...
EchoNous, an innovator focused on delivering intelligent medical tools, announces the release of EchoNous Bladder™, a highly reliable, all-electronic, non-mechanical, bladder scanning tool for nurses. To help nurses quickly determine bladder volume of patients, EchoNous Bladder combines data-rich fanning, a state-of-the-
Laura J. Esserman, MD, MBA, a 2018 Giants of Cancer Care® award winner in the Cancer Diagnostics category led the way in designing the I-SPY clinical trials, a groundbreaking effort to match patients with breast cancer to potential therapies based on molecular drivers of disease. She also has advocated for a greater understanding of the biological drivers of breast cancer, rather than relying ...
The EMA needs to fix problems with the clinical trial registry to improve reporting across Europe, says TranspariMED founder, as seemingly small issues can âseriously hinder compliance.â
Alesha MacPhail murder trial: Jury told of DNA Google search BBC NewsAlesha MacPhail trial UPDATES: Accused teen's phone 'used to Google "How do police find DNA"' Mirror.co.ukAlesha MacPhail: Boy accused of killing six-year-old 'told police "no comment"' Daily MailAlesha MacPhail murder trial in Glasgow hears what the accused replied when he was charged Evening TimesAlesha: Knife found on beac...
Medality Medical said the device, which was designed by its founder Mark Andrew, can gently and selectively extract excess mesenteric visceral fat, which has been associated with insulin The post Medality Medical wins FDA IDE approval for reversal of type 2 diabetes clinical trial appeared first on Compelo Medical Devices.
Fresenius Kabi is a global health care company that specializes in medicines and technologies for infusion, transfusion and clinical nutrition. The Fenwal Amicus RBCx system allows for the The post Fresenius Kabi gets 510(k) clearance for Fenwal Amicus red blood cell exchange protocol appeared first on Compelo Medical Devices.
Surmodics, Inc. (NASDAQ: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced the appointment of Timothy J. Arens, Vice President of Corporate Development and Strategy, as the company’s new Chief Financial Officer (CFO), effective immediately. Arens was named inter...
Ongoing and future clinical trials in second-line primary biliary cholangitis (PBC) are likely to face Intercept Pharmaceuticals’ Ocaliva (obeticholic acid)...Read More... The post Ocaliva poses enrolment obstacle in liver disease clinical trials appeared first on Pharmaceutical Technology.
Hurricanes, wildfires, power outages, and flooding all threaten manufacturing facilities and research sites. Find out how biopharma is girding for #climatechange. https://buff.ly/2EhZ31z
The Automation of Neonatal Critical Congenital Heart Disease (CCHD) Screening Across More Than 370 Healthcare Facilities Is Expected to Improve the Process of Screening More Than 550,000 Newborns Annually by 2020 Recently at Arab Health 2019, the Saudi Arabia Ministry of Health (MOH) and Masimo (NASDAQ: MASI) jointly announced the implement...
Saama Technologies, Inc., a leading data analytics company, today unveiled three new, machine learning-based capabilities that extend the existing functionality of its award-winning Life Science Analytics Cloud (LSAC). Saama announced the addition of these state-of-the-art programs infused with a
Asana BioSciences to Present Correlation Between Microbiome Changes and Clinical Efficacy With JAK/SYK Inhibitor ASN002 in the Late-Breaking News Session at the American Academy of Dermatology (AAD) Annual Congress
First demonstration of changes in Staphylococcus aureus in lesional skin, correlating with clinical efficacy Asana BioSciences, a clinical stage biopharmaceutical company, announced that it will present ASN002 data demonstrating changes in skin microbiome and correlation with clinical efficacy in patients with moderate-to-severe atopic dermat...
Japanese pharma firm Astellas has lifted the curtain on new data for its androgen receptor signalling inhibitor Xtandi (enzalutamide), when combined with androgen deprivation therapy (ADT), in the treatment of male patients with metastatic hormone-sensitive prostate cancer (mHSPC). It was found that the combination met its primary endpoint in Phase 3 trials, significantly reducing the risk of radi...
Lundbeck's Rexulti has failed to achieve the primary endpoint of two Phase III bipolar disorder studies.
Seasoned senior executive appointed to steer the ship of quality patient care delivery ATLANTA (PRWEB) February 18, 2019 In a bid to continually uphold its commitment to quality patient care and service delivery, Perimeter Healthcare is delighted to unveil Angela Boring as its new Vice President of Clinical Services, Quality, and Risk Management. Boring possesses a huge wealth of experience in th...
The Kroger Family of Pharmacies has worked with Houston-based MarkeTouch Media to apply an innovative and unique method of assisting patients through medication synchronization (“MedSync”). HOUSTON (PRWEB) February 18, 2019 The Kroger Family of Pharmacies has worked with Houston-based MarkeTouch Media to apply an innovative and unique method of assisting patients through medication synchroniz...
Exicure, Inc. (OTCQB:XCUR), the pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) constructs, announced today that its CEO, Dr. David Giljohann, will present at SMi’s RNA Therapeutics 2019 Conference being held February 20-21, 2019 at the Copthorne Tara Hotel in London, UK. Dr. Giljohann’s presentation tit...
Global students may take U.S. medical school curriculum and obtain Doctor of Medicine (MD) degree through study in the U.K. and U.S. As many countries face a severe current and future doctor shortage, the American University of the Caribbean School of Medicine (AUC) and the University of Central Lancashire (UCLan) announced a new program aimed at helpi...
What are the benefits of parathyroid hormone monitoring during surgery for primary hyperparathyroidism? Clinical Endocrinology
Pfizer and German-based Merck Group have published promising interim results from their Phase III JAVELIN Renal 101 trial evaluating the...Read More... The post Merck Group and Pfizer announce positive results for combo therapy for RCC appeared first on Pharmaceutical Technology.
Seasoned Machine Learning and Medical Imaging Technology Executive Joins Paige.AI After Leading Successful Product Development Efforts at HeartFlow Paige.AI, the leading start-up focused on transforming clinical diagnosis and treatment in pathology and oncology through the use of artificial intelligence (AI), today announced that Dr. Leo Grady has ...